| NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy W Wang, AK Erbe, JA Hank, ZS Morris, PM Sondel Frontiers in immunology 6, 368, 2015 | 716 | 2015 |
| Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology M Von Mehren, RL Randall, RS Benjamin, S Boles, MM Bui, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 16 (5), 536-563, 2018 | 649 | 2018 |
| Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? S Demaria, C Guha, J Schoenfeld, Z Morris, A Monjazeb, A Sikora, ... Journal for immunotherapy of cancer 9 (4), e002038, 2021 | 196 | 2021 |
| Development of an in situ cancer vaccine via combinational radiation and bacterial‐membrane‐coated nanoparticles RB Patel, M Ye, PM Carlson, A Jaquish, L Zangl, B Ma, Y Wang, I Arthur, ... Advanced Materials 31 (43), 1902626, 2019 | 190 | 2019 |
| Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade RB Patel, R Hernandez, P Carlson, J Grudzinski, AM Bates, ... Science translational medicine 13 (602), eabb3631, 2021 | 158 | 2021 |
| In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments ZS Morris, EI Guy, DM Francis, MM Gressett, LR Werner, LL Carmichael, ... Cancer research 76 (13), 3929-3941, 2016 | 158 | 2016 |
| The promise of combining radiation therapy with immunotherapy JC Jagodinsky, PM Harari, ZS Morris International Journal of Radiation Oncology* Biology* Physics 108 (1), 6-16, 2020 | 136 | 2020 |
| Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology RG Bristow, B Alexander, M Baumann, SV Bratman, JM Brown, ... The Lancet Oncology 19 (5), e240-e251, 2018 | 127 | 2018 |
| Interaction of radiation therapy with molecular targeted agents ZS Morris, PM Harari Journal of Clinical Oncology 32 (26), 2886-2893, 2014 | 115 | 2014 |
| Results of the 2013-2015 association of residents in radiation oncology survey of chief residents in the United States N Nabavizadeh, LM Burt, BR Mancini, ZS Morris, AJ Walker, SM Miller, ... International Journal of Radiation Oncology* Biology* Physics 94 (2), 228-234, 2016 | 88 | 2016 |
| Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites ZS Morris, EI Guy, LR Werner, PM Carlson, CM Heinze, JS Kler, ... Cancer immunology research 6 (7), 825-834, 2018 | 78 | 2018 |
| NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin C Chiasson-MacKenzie, ZS Morris, Q Baca, B Morris, JK Coker, ... Journal of Cell Biology 211 (2), 391-405, 2015 | 77 | 2015 |
| Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma ZS Morris, AI McClatchey Proceedings of the National Academy of Sciences 106 (24), 9767-9772, 2009 | 72 | 2009 |
| Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition J Voeller, AK Erbe, J Slowinski, K Rasmussen, PM Carlson, A Hoefges, ... Journal for ImmunoTherapy of Cancer 7, 1-13, 2019 | 69 | 2019 |
| 90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin’s Lymphoma R Hernandez, KL Walker, JJ Grudzinski, E Aluicio-Sarduy, R Patel, ... Communications biology 2 (1), 79, 2019 | 58 | 2019 |
| Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy JC Jagodinsky, WJ Jin, AM Bates, R Hernandez, JJ Grudzinski, IR Marsh, ... Theranostics 11 (13), 6120, 2021 | 55 | 2021 |
| Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers ZS Morris, S Saha, WJ Magnuson, BA Morris, JF Borkenhagen, A Ching, ... Cancer 122 (16), 2487-2495, 2016 | 55 | 2016 |
| The radiobiology of radiopharmaceuticals ZS Morris, AZ Wang, SJ Knox Seminars in radiation oncology 31 (1), 20-27, 2021 | 54 | 2021 |
| Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade Y Zhang, RN Sriramaneni, PA Clark, JC Jagodinsky, M Ye, W Jin, Y Wang, ... Nature communications 13 (1), 4948, 2022 | 53 | 2022 |
| Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane: cytoskeleton interface C Chiasson-MacKenzie, ZS Morris, CH Liu, WB Bradford, T Koorman, ... Genes & development 32 (17-18), 1201-1214, 2018 | 47 | 2018 |
